Author

Maen Hussain

Institution: Florida Cancer Specialists & Research Institute

Observed institution: Florida Cancer Specialists & Research Institute

OpenAlex ID: A5114054979

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer

2023 · Gregory J. Riely, Egbert F. Smit, et al. · Journal of Clinical Oncology · 128

Works count: 1

Citation count: 128

H-index: 1

I10-index: 1